Cell Metabolism

Cell Metabolism (Cell Metab.) is a metabolism research journal published by Cell Press. Founded in January 2005, it is among the highest-impact primary research titles in metabolism, concentrates on the molecular mechanisms of metabolic regulation and their role in disease, appears monthly, and had a 2025 impact factor of 37.0.《细胞代谢》（Cell Metabolism''''，缩写 Cell Metab.''）是细胞出版社出版的代谢研究刊物，2005 年 1 月创刊，是代谢领域影响因子最高的原始研究刊物之一。该刊以代谢调控的分子机制及其在疾病中的作用为主，现为月刊，二〇二五年影响因子为 37.0。

Scope

The journal's editorial stance is that metabolism has to be explained mechanistically: however complete the phenotype, a paper must give the molecular or cellular mechanism of metabolic regulation and show what it means for physiological homeostasis or disease. Coverage runs from molecular mechanism to clinical translation and concentrates on:本刊的取稿立场是「以机制解释代谢」：一篇论文不论表型多么完整，都要给出代谢调控的分子或细胞机制，并说明它在生理稳态或疾病中的意义。收文覆盖从分子机制到临床转化的多个层次，重点包括：

• Cellular metabolism and homeostasis: nutrient sensing and metabolic pathways, organellar metabolism and mitochondrial function, transcriptional and epigenetic control of metabolism, and circadian rhythms and feeding behaviour.细胞代谢与生理稳态： 营养感知与代谢通路、细胞器代谢与线粒体功能、代谢的转录与表观调控、昼夜节律与进食行为。

• Diabetes, obesity and the islet: beta-cell function and failure, mechanisms of insulin resistance, neuroendocrine control of obesity, and diabetic complications.糖尿病、肥胖与胰岛： 胰岛β细胞功能与衰竭、胰岛素抵抗的机制、肥胖的神经内分泌调控、糖尿病并发症。

• Adipose tissue and lipid metabolism: adipocyte differentiation and thermogenesis, lipid droplet biology, cholesterol and lipoprotein metabolism, and lipidomics and non-alcoholic fatty liver disease.脂肪组织与脂质代谢： 脂肪细胞分化与产热、脂滴生物学、胆固醇与脂蛋白代谢、脂质组学与非酒精性脂肪肝。

• Cardiovascular and immunometabolism: mechanisms of cardiometabolic disease, metabolic reprogramming of immune cells, the interplay of inflammation and metabolism, and the immune microenvironment of metabolic tissues.心血管与免疫代谢： 心血管代谢病机制、免疫细胞的代谢重编程、炎症与代谢的交互、代谢组织中的免疫微环境。

• Ageing and stress: metabolism and lifespan control, nutrient restriction and autophagy, oxidative and endoplasmic reticulum stress, and compensation and decompensation of metabolic homeostasis.衰老与应激： 代谢与寿命调控、营养限制与自噬、氧化与内质网应激、代谢稳态的代偿与失代偿。

• Cancer metabolism and translation: metabolic reprogramming in tumours, signalling by metabolic enzymes and metabolites, therapeutic potential of metabolic intervention, and population and clinical evidence.癌症代谢与转化研究： 肿瘤代谢重编程、代谢酶与代谢物信号、代谢干预的治疗潜力、人群与临床研究证据。

The journal is hybrid, with content moving to delayed open access twelve months after publication, and the gold open access article processing charge is 10,400 US dollars. The publisher reports seven days to first editorial decision, 187 days to acceptance and 28 days from acceptance to online publication, the first-decision figure including editorial screening本刊为混合出版，未发表后十二个月转为延迟开放，金色开放获取的文章处理费为一万零四百美元；出版方公布投稿至首次编辑决定七天、投稿至接收一百八十七天、接收至线上二十八天，其中首次决定包含编辑部初筛，录用比例未公布。 no acceptance rate is published.^[1]

History

• Founding (2005): volume 1, issue 1 appeared in January 2005. According to the journal's twentieth-anniversary editorial, the rationale was that the metabolism community needed a home of its own, a top-tier primary research journal devoted specifically to metabolic research.创刊（2005年）： 2005 年 1 月出版第 1 卷第 1 期。据该刊创刊二十周年社论，创刊动因是代谢学界需要一个属于自己的家园，即一个专门面向代谢研究的顶级原始研究刊物。^[2]

• Twenty years and scale (2025): 2025 marked the journal's twentieth year, marked by commemorative content reviewing two decades of change in metabolism research. The journal now publishes one volume of twelve issues a year and has reached volume 37.二十年与体量（2025年）： 2025 年为本刊创刊二十周年，出版方组织纪念内容并回顾代谢研究二十年间的领域变化；本刊现每年一卷十二期，卷号已排至第 37 卷。

• Publishing model: the journal is not a gold open access title but uses a hybrid model with delayed open access after twelve months, with paid immediate open access available to authors. The arrangement divides labour with the fully open access titles launched by Cell Press in the same period.出版模式： 本刊并非金色开放获取刊物，采用混合出版加十二个月延迟开放的模式，作者可选择付费即时开放；这一模式与细胞出版社同期创办的完全开放获取刊物形成分工。

• Metrics and indexing: the impact factor is 37.0 and the CiteScore 54.1, on the 2025 Journal Citation Reports released by Clarivate in 2026. The journal is indexed in Scopus and MEDLINE, and holding a Journal Citation Reports impact factor means it is covered by the Science Citation Index Expanded.指标与收录： 影响因子 37.0、引用分数 54.1，数据为科睿唯安 2026 年发布的 2025 年期刊引证报告口径；本刊被 Scopus 与 MEDLINE 收录，并取得期刊引证报告影响因子即表明被科学引文索引扩展版收录。^[1]

Editors

The journal follows the Cell Press in-house professional editor model, in which the editor-in-chief is a professional editor appointed within the publisher rather than a researcher holding an academic post. The present editor is based in the Madrid office and her two predecessors were based in house in the United States.本刊实行细胞出版社内部专业编辑制，主编由出版社内部任命的专业编辑担任，而非由学术机构的研究者兼任；现任主编驻社马德里办公室，前两任分别驻社内与社内美国办公室。^[3]

• Present editor: Salvatore Fabbiano is an in-house professional editor at Cell Press based in the Madrid office and took up the post in 2025, having previously served as a senior editor on the journal.现任主编： （Salvatore Fabbiano）为细胞出版社内部专业编辑，驻马德里办公室，2025 年就任；此前任该刊副主编。

• Past editors: Nikla Emambokus served from 2010 to 2019 and Allyson Evans from 2019 to 2025. The publisher has not made public the identity of the founding editor for the years from 2005 to 2010, and this is recorded as not published.历任主编： （Nikla Emambokus）2010 年至 2019 年在任；（Allyson Evans）2019 年至 2025 年在任；创刊至 2010 年间的首任主编出版方未公开，按未公布处理。^[4]

• Role in the field: the journal raised metabolism from a branch of physiology to a distinct top-tier journal field. Its work on nutrient sensing and metabolic reprogramming is often treated as defining for the area, and it led Cell Press to launch further metabolism-oriented sister titles.学科角色： 本刊把代谢研究从生理学的一个分支提升为独立的顶级刊领域，其刊载的营养感知与代谢重编程工作常被视为该领域的定义性成果，也带动细胞出版社后续设立代谢方向的姊妹刊。